✦ LIBER ✦

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age

✍ Scribed by Gustavo H. Dayan; Joan Bevilacqua; Dorothy Coleman; Aileen Buldo; George Risi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability, and immunogenicity

✍ Joost N. Vermeulen; Joep M.A. Lange; Stephen K. Tyring; Patrick H. Peters; Marga 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Safety and immunogenicity of revaccinati

✍ Gorse, Geoffrey J.; Falsey, Ann R.; Johnson, Carol M.; Morrison, Dennis; Fried, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 760 KB

Comparative study of the immunogenicity

✍ Gilbert M. Schiff; James R. Sherwood; Jerome B. Zeldis; David S. Krause 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 394 KB

Comparative study of the immunogenicity

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Immunogenicity, safety and tolerability

✍ Joseph Torresi; Karen McCarthy; Emmanuel Feroldi; Claude Méric 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Dose-ranging studies of the safety and i

✍ Kenneth H Fife; Cosette M Wheeler; Laura A Koutsky; Eliav Barr; Darron R Brown; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 146 KB